Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence.
about
Oral cavity and oropharyngeal squamous cell carcinoma--an updateEvasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.HPV in oropharyngeal cancer: the basics to know in clinical practiceIs radiation dose reduction the right answer for HPV-positive head and neck cancer?What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?Higher micronutrient intake is associated with human papillomavirus-positive head and neck cancer: a case-only analysisThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisComprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristicsManagement of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.Clinical and molecular characteristics of HNSCC patients with brain metastases: a retrospective study.High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods.Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patientsManagement of oropharyngeal cancer: a cross-sectional review of institutional practice at a large Canadian referral centre.Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancerHuman papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumorOral epithelial stem cells - implications in normal development and cancer metastasis.Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival.Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapyPrognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.Geriatric oncology: comparing health related quality of life in head and neck cancer patients.Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancerHuman Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK populationHuman papillomavirus infection in 674 Chinese patients with laryngeal squamous cell carcinomaQuality of life in head and neck cancer patients: impact of HPV and primary treatment modality.Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis.Human papillomavirus, smoking, and head and neck cancerProton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinomaDiscrimination of 'driver' and 'passenger' HPV in tonsillar carcinomas by the polymerase chain reaction, chromogenic in situ hybridization, and p16(INK4a) immunohistochemistry.Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 studyImpact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy.Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas.The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategiesStereotactic body radiotherapy for recurrent oropharyngeal cancer - influence of HPV status and smoking history.Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study.Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neckPopulation-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer.UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line
P2860
Q26799210-D34C37B5-C6F3-4A1F-8BCC-ADDF19400321Q26827810-9375F30E-C355-4D25-A23F-0ACEF5DD7573Q26853669-2CD90B38-16AD-41DB-9BAF-08A4DF62C5EAQ27024764-93833EDD-C187-43AF-A809-25F1C486A3CBQ27026269-C3BC7B16-0B0B-4826-A379-B26A689ABC84Q28386178-8E073815-0F1B-470F-A753-B18BF2D212E0Q28388257-5D572D1C-F081-4179-8770-211414FB4CC5Q28485279-8C751FF9-B585-4AD4-A74A-AC3F38E86C48Q30252081-63B25E9B-72D2-46A0-9EAC-65AB5D78EFE3Q30373904-C6EE52C3-B737-448C-9480-858B9C3A66FFQ31127773-E69EF6D4-3C62-4D4A-AC4B-1094FA38261AQ33726331-532C90E3-4C63-42F9-8A50-33F8E420A9AAQ33901342-36180914-BCA7-4111-9FA3-5A434781F98FQ33936862-66D7FAE4-4D30-4219-A40A-613033455154Q33986942-3A200BD6-78D1-40EC-A745-C62ABDB2C8B4Q34129454-CF79F16E-618E-4EB6-BA12-4C6057BFAB70Q34147649-BCFA986A-4EB8-4F7D-9CB2-9D0AD16A19BBQ34342397-DCD47664-7FC0-4793-A045-10D4F1057307Q34344038-41668A37-066C-41DD-BDA8-F77517330D0BQ34394972-D64E01EA-80EA-4B09-905C-6AC3C0772BCBQ34547468-5E7283EC-8BCA-42EF-AD85-0A9C2D3576D1Q34667840-0714CD57-0B2A-4FBD-B25A-317F8F4302C2Q34698871-454DE863-4AAA-4B5D-8BD7-56FF11660F4FQ34764776-FF347A85-275A-41DB-914C-B9F4021D6D1EQ35071687-6C92CF80-F46C-4737-B6AB-F04A048E4390Q35124426-45045715-7697-4DF2-844B-64E051FF70B2Q35161119-84028779-D5C0-4F43-BDBC-D809A04F867AQ35214908-0E17FCAF-7D3F-4DAF-AA4A-074623292397Q35533875-1FE8A18E-1D18-4135-9554-FAF1DDF07D53Q35602143-111D7707-EE07-4E68-97F7-BB3BC36C143EQ35669647-C863C290-D8E2-4F0A-88E9-BBE356BAC3F3Q35673572-0D551D89-EF3F-4A28-A6DE-6D75CA51D598Q35762184-81D66435-EC8A-4718-B7C8-20D8D4131ACAQ35827866-B2ABB05B-1368-4767-BFA6-FE37844D2CE3Q35838231-90917898-D9F4-4DB2-BD69-9D35E7B39DACQ35861606-25B369ED-6738-4D60-AD1E-5C03610635A3Q35870672-97FDCA0C-5E9B-4DB2-A0EA-51F3DA2CA2CEQ35917835-FC96BFD0-9F5F-4AD9-8987-91C08C734CDDQ35990622-BA5A22A5-D622-482C-A56D-57F8843BF2AFQ36013039-CE875209-1FAF-4EBF-9C66-F8DC3979E2E4
P2860
Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tobacco use in human papilloma ...... tastases and tumor recurrence.
@ast
Tobacco use in human papilloma ...... tastases and tumor recurrence.
@en
type
label
Tobacco use in human papilloma ...... tastases and tumor recurrence.
@ast
Tobacco use in human papilloma ...... tastases and tumor recurrence.
@en
prefLabel
Tobacco use in human papilloma ...... tastases and tumor recurrence.
@ast
Tobacco use in human papilloma ...... tastases and tumor recurrence.
@en
P2093
P2860
P1476
Tobacco use in human papilloma ...... tastases and tumor recurrence.
@en
P2093
Bhavna Kumar
Carol R Bradford
David M Kurnit
Douglas B Chepeha
Felix Y Feng
Francis P Worden
Gregory T Wolf
Heather M Walline
Jay Stoerker
Jeffrey S Moyer
P2860
P304
P356
10.1158/1078-0432.CCR-09-2350
P407
P577
2010-02-09T00:00:00Z